Hepatitis C Testing Recommendationsdepts.washington.edu/hepstudy/presentations/... · Source: Rein,...
Transcript of Hepatitis C Testing Recommendationsdepts.washington.edu/hepstudy/presentations/... · Source: Rein,...
Hepatitis web study
HEPATITIS WEB STUDY
Christian B. Ramers, MD, MPH Assistant Medical Director, Family Health Centers of San Diego HIV/HCV Distance Education Specialist, Northwest AETC University of Washington School of Medicine
Hepatitis C Testing Recommendations
Last Updated: February 28, 2013
Hepatitis web study
Disclosure Information
• Speaker’s Bureau and Consultant: Gilead Sciences
Hepatitis web study
Hepatitis web study
§ CDC HCV Testing Recommendation
§ Rationale for Birth Cohort HCV Testing Recommendations
§ Goals and Potential Impact of HCV Birth Cohort Testing
Hepatitis C Testing Recommendations in the U.S.
Hepatitis web study
Hepatitis web study
CDC HCV Testing Recommendations
Hepatitis web study
1998 – CDC Risk-Based HCV Screening Recommendations
Source: CDC and Prevention.
• Persons who ever injected illegal drugs
• Persons with selected medical conditions, including - receipt of clotting factor concentrates produced before 1987; - ever on chronic (long-term) hemodialysis; and - persistently abnormal alanine aminotransferase levels
• Prior recipients of transfusions or organ transplants (before July 1992)
§ HCV screening based on risk for infection:
• Healthcare, emergency medical, and public safety workers after needle sticks, sharps, or mucosal exposures to HCV-positive blood
• Children born to HCV-positive women
§ HCV screening based on recognized exposure:
Hepatitis web study
Hepatitis web study Source: CDC and Prevention. MMWR. 2012:RR61:1-32.
Recommendations and Reports / Vol. 61 / No. 4 August 17, 2012
Recommendations for the Identification of Chronic Hepatitis C Virus Infection Among
Persons Born During 1945–1965
U.S. Department of Health and Human ServicesCenters for Disease Control and Prevention
Morbidity and Mortality Weekly Report
Continuing Education Examination available at http://www.cdc.gov/mmwr/cme/conted.html.
Hepatitis web study
2012 CDC Birth Cohort HCV Testing Recommendations
In addition to testing adults of all ages at risk for hepatitis C virus:
§ Adults born during 1945 to 1965 should receive 1-time testing for HCV without prior ascertainment of HCV risk.
§ All persons identified with HCV infection should receive: - A brief alcohol screening and intervention as clinically indicated, - Referral to appropriate care and treatment services for HCV infection, - Post-test counseling
Source: Source: CDC and Prevention. MMWR. 2012:RR61:1-32.
Hepatitis web study
Hepatitis C Testing Methods
Y Y Y • Screening: Hepatitis C Antibody Testing - Highly sensitive and specific - Reactive test indicates current or resolved infection
• Supplemental: Nucleic Acid Testing - Quantitative and qualitative HCV RNA tests used - Positive test indicates active infection
Hepatitis web study
Hepatitis web study
Rationale for Birth Cohort HCV Testing Recommendations
Hepatitis web study
1968 World Health Organization Guidelines Criteria for New Screening Programs
When considering general public health screening programs, the following factors should be considered:
§ Relevance: Is the condition an important public health problem with a well-understood natural history and a latent phase?
§ Feasibility: Is there an effective intervention? Is a screening test available, easy to use, accurate, and acceptable to the population?
§ Effectiveness: Does early diagnosis and treatment affect outcomes?
§ Cost Effectiveness: Is the cost of the screening program worth the investment in terms of health benefit gained?
Adapted from: Wilson JMG and Jungner G. Principles and Practice of Screening for Disease. WHO. 1968.
Hepatitis web study
Sources: Armstrong GL, et al. Ann Intern Med. 2006;144:705-14. Chak E, et al. Liver Int. 2011;31:1090-101.
Estimated Prevalence of Chronic Active Hepatitis C in U.S.
3.2 - 4.1 Million Persons Living with Chronic HCV
Hepatitis web study Source: Ly KN, et al. Ann Intern Med. 2012:156:271-8.
Age-Adjusted Mortality Rates from HBV, HCV, & HIV United States, 1999-2007
Rat
e pe
r 100
,000
PY
Year
HIV
1999 2000 2001 2002 2003 2004 2006 2007 2005
5
4
3
2
1
0
7
6
Hepatitis C
Hepatitis B
Hepatitis web study Source: Rein DR, et al. Dig Liver Dis. 2011:43:66-72.
Forecasted 2010-2060 Annual HCV-Related Deaths in the United States Persons with Chronic Hepatitis C and no Cirrhosis in 2005
Num
ber
Year
2010
Deaths
2014 2018 2022 2026 2030 2034 2038 2042 2046 2050 2054 2058
40,000
35,000
30,000
25,000
20,000
15,000
10,000
5,000
0
45,000
Hepatitis web study Source: Rein DR, et al. Dig Liver Dis. 2011:43:66-72.
Forecasted 2010-2060 Annual HCV-Related Deaths in the United States Persons with Chronic Hepatitis C and no Cirrhosis in 2005
Num
ber
Year
2010
Deaths
2014 2018 2022 2026 2030 2034 2038 2042 2046 2050 2054 2058
40,000
35,000
30,000
25,000
20,000
15,000
10,000
5,000
0
45,000 Peak
Hepatitis web study Source: Rein DR, et al. Dig Liver Dis. 2011:43:66-72.
Forecasted 2010-2060 Annual HCV-Related Deaths in the United States Persons with Chronic Hepatitis C and no Cirrhosis in 2005
Num
ber
Year
2010
Deaths
2014 2018 2022 2026 2030 2034 2038 2042 2046 2050 2054 2058
40,000
35,000
30,000
25,000
20,000
15,000
10,000
5,000
0
45,000
Without treatment an estimated 1,071,229 persons will have died from hepatitis C by 2060
Hepatitis web study Source: Denniston M, et al. Hepatology. 2012:55:1652-61.
NHANES Survey, United States, 2001-2008 Awareness of HCV Infection Status
Unaware of HIV infection
21%
Knowledge of HCV Infection
Aware!50%!
Unware !50%!
Hepatitis web study
Source: WHO Hepatitis C Fact Sheet http://www.who.int/immunization/topics/hepatitis_c/en/index.html
Burden of disease related to HCV
Outcome Key Facts
Cirrhosis • Develops in 20% of those who are chronically infected with HCV over 20-30 years
Decompensated Cirrhosis • High risk of mortality from ruptured esophageal
varices, bacterial peritonitis, hepatorenal syndrome/renal failure, encephalopathy
Hepatocellular Carcinoma • Fastest growing Cancer in the US • 76% associated with chronic HCV infection • 4% annual incidence in those with cirrhosis
Liver Transplantation • HCV responsible for 65% of liver transplants worldwide
HCV Mortality • Estimated at 16,000/year • Likely to peak ~2030
Burden of Liver disease expected to triple in next 10-20 yrs
Hepatitis web study
Therapy for Hepatitis C: Historical Milestones
6
16
34 42 39
55
70
0
20
40
60
80
100
IFN 6m
IFN 12m
IFN + RBV 6m
IFN + RBV 12m
PegIFN 12m
PegIFN + RBV 12m
PegIFN + RBV + PI
6-12m
Sust
aine
d Vi
rolo
gic
Res
pons
e (%
) 1986 1998 2001 2002
Timeline 2011
Hepatitis web study
Therapy for Hepatitis C Projected SVR Rates with Multiple DAAs
6 16
34 42 39
55
70
90
0
20
40
60
80
100
IFN 6m
IFN 12m
IFN + RBV 6m
IFN + RBV 12m
PEG 12m
PEG + RBV 12m
PEG + RBV + PI
6-12m
Multiple DAAs
3m
Sust
aine
d Vi
rolo
gic
Res
pons
e (%
)
1986 1998 2001 2002
Timeline 2011 2014
Hepatitis web study Source: Armstrong GL, et al. Ann Intern Med. 2006;144:705-14.
NHANES Survey: United States, 1988-1994 and 1999-2002 Prevalence of HCV Antibody, by Year of Birth
Year of Birth
HC
V Pr
eval
ence
(%)
1910
1988–1994 1999–2002 7.0
6.0
5.0
4.0
3.0
2.0
1.0
0 1920 1930 1940 1950 1960 1970 1980 1990
Hepatitis web study Source: Armstrong GL, et al. Ann Intern Med. 2006;144:705-14.
NHANES Survey: United States, 1988-1994 and 1999-2002 Prevalence of HCV Antibody, by Year of Birth
Year of Birth
HC
V Pr
eval
ence
(%)
1910
1988–1994 1999–2002 7.0
6.0
5.0
4.0
3.0
2.0
1.0
0 1920 1930 1940 1950 1960 1970 1980 1990
1945-1965
Hepatitis web study
Rationale for One-Time HCV Testing of All Persons Born in United States during 1945 to 1965
• Hepatitis C is a major current & future health problem in United States
• Testing can identify persons before onset of severe HCV-related disease
• Hepatitis C infection can be cured with treatment
• Bulk of HCV problem in United States involves persons born 1945-1965
• Approximately 50% of persons with HCV remain unaware of HCV status
Hepatitis web study
Hepatitis web study
Goals and Projected Impact of Birth-Cohort Screening
Hepatitis web study
Goals for Birth Cohort Hepatitis C Testing in U.S.
Improve Survival &
Quality of Life
Prevent New HCV Infections
HCV Testing
HCV Diagnosis Treat HCV Link to Care
for HCV
Hepatitis web study
Goals for Birth Cohort Hepatitis C Testing in U.S.
Improve Survival &
Quality of Life
Prevent New HCV Infections
HCV Testing
HCV Diagnosis
Link to Care for HCV
Hepatitis web study
HCV Testing of Persons in 1945-1965 Birth Cohort CDC Recommendations for Post Test Counseling
• Refer or obtain advice for care of HCV - experienced primary care provider or specialist
• Educate patient on how to protect liver from further harm - Immunization against Hepatitis A and B - Brief alcohol screening and intervention - Limit exposure to hepatotoxic drugs (e.g. acetaminophen)
• Counsel obese patients on diet & weight Loss - Especially BMI ≥25kg/m2
• Advise on decreasing risk of transmission to others - Donation of blood, tissue, semen - Use of razors, toothbrushes, nail clippers
Source: CDC and Prevention. MMWR. 2012:61(RR-4):1-32.
Hepatitis web study
HCV Testing of Persons Born 1945-1965 Projected Benefit of One Time Birth Cohort Testing
Clinical Outcomes Associated with Risk Based versus Birth Cohort HCV Testing
Source: Rein DB, et al. Ann Intern Med. 2012:156:263-70.
994,291
360,388
230,784
75,752
591,172
791,053
286,699
183,595
60,268
470,879
0
200000
400000
600000
800000
1000000
1200000
Compensated Cirhosis
Decompensated Cirhosis
Hepatocellular Carcinoma
Liver Transplant HCV-Related Deaths
Pers
ons
Risk-Based Testing + PR
Birth-Cohort Screening + PR and DAA
Hepatitis web study
HCV Testing of Persons Born 1945-1965 Projected Benefit of One Time Birth Cohort Testing Cases Averted with Birth Cohort HCV Testing versus Risk Based HCV Testing
Source: Rein DB, et al. Ann Intern Med. 2012:156:263-70.
-203,238
-73,689
-47,189
-15,484
-120,879
-250000
-200000
-150000
-100000
-50000
0
Compensated Cirhosis
Decompensated Cirhosis
Hepatocellular Carcinoma Liver Transplant
HCV-Related Deaths
Diff
eren
ce
Hepatitis web study Source: Rein, DB et al Ann Intern Med 2012:156:263-70.
HCV Testing of Persons Born 1945-1965 Cost Effectiveness Compared with other Screening Tests
49,000
38,000
35,700
30,000
15,700
11,000
0 10000 20000 30000 40000 50000 60000
Breast CA Screening (> age 40)
HIV Screening (age 13-64)
HCV Screen (1945-65) + PEG-IFN/RIB/DAA
HTN Screening (> age 18)
HCV Screen (1945-65) + PEG-IFN/RIB
Colorectal CA (> age 50)
Cost per QALY ($)
Hepatitis web study
Hepatitis web study
§ Perform one-time HCV testing of all persons born 1945-1965
§ Continue risk-based HCV screening
§ Sound rationale exists for birth-cohort screening
§ Potential for large impact of birth-cohort testing
CDC Birth Cohort HCV Testing Recommendations in U.S. : Summary
Hepatitis web study
Hepatitis web study
End
This presentation is brought to you by Hepatitis Web Study & the Hepatitis C Online Course
Funded by a grant from the Centers for Disease Control and Prevention